BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38494510)

  • 1. Reproductive outcomes in women opting for fertility preservation after fertility-sparing surgery for borderline ovarian tumors.
    Cosyns S; Van Moer E; De Quick I; Tournaye H; De Vos M
    Arch Gynecol Obstet; 2024 May; 309(5):2143-2152. PubMed ID: 38494510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fertility preservation after fertility-sparing surgery in women with borderline ovarian tumours.
    Khiat S; Provansal M; Bottin P; Saias-Magnan J; Metzler-Guillemain C; Courbiere B
    Eur J Obstet Gynecol Reprod Biol; 2020 Oct; 253():65-70. PubMed ID: 32784054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining fertility preservation procedures to spread the eggs across different baskets: a feasibility study.
    Delattre S; Segers I; Van Moer E; Drakopoulos P; Mateizel I; Enghels L; Tournaye H; De Vos M
    Hum Reprod; 2020 Nov; 35(11):2524-2536. PubMed ID: 32951035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Fertility].
    Raad J; Rolland L; Grynberg M; Courbiere B; Mathieu d'Argent E
    Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):330-336. PubMed ID: 32004782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Live birth rate after female fertility preservation for cancer or haematopoietic stem cell transplantation: a systematic review and meta-analysis of the three main techniques; embryo, oocyte and ovarian tissue cryopreservation.
    Fraison E; Huberlant S; Labrune E; Cavalieri M; Montagut M; Brugnon F; Courbiere B
    Hum Reprod; 2023 Mar; 38(3):489-502. PubMed ID: 36421038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fertility-sparing surgery and reproductive-outcomes in patients with borderline ovarian tumors.
    Plett H; Harter P; Ataseven B; Heitz F; Prader S; Schneider S; Heikaus S; Fisseler-Eckhoff A; Kommoss F; Lax SF; Staebler A; Traut A; du Bois A
    Gynecol Oncol; 2020 May; 157(2):411-417. PubMed ID: 32115229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Live births following fertility preservation using in-vitro maturation of ovarian tissue oocytes.
    Segers I; Bardhi E; Mateizel I; Van Moer E; Schots R; Verheyen G; Tournaye H; De Vos M
    Hum Reprod; 2020 Sep; 35(9):2026-2036. PubMed ID: 32829388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reproductive and obstetrical outcomes with the overall survival of fertile-age women treated with fertility-sparing surgery for borderline ovarian tumors in Sweden: a prospective nationwide population-based study.
    Johansen G; Dahm-Kähler P; Staf C; Flöter Rådestad A; Rodriguez-Wallberg KA
    Fertil Steril; 2021 Jan; 115(1):157-163. PubMed ID: 32977941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 10-year follow-up of reproductive outcomes in women attempting motherhood after elective oocyte cryopreservation.
    Loreti S; Darici E; Nekkebroeck J; Drakopoulos P; Van Landuyt L; De Munck N; Tournaye H; De Vos M
    Hum Reprod; 2024 Feb; 39(2):355-363. PubMed ID: 38145619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Borderline ovarian tumors: French guidelines from the CNGOF. Part 2. Surgical management, follow-up, hormone replacement therapy, fertility management and preservation.
    Bourdel N; Huchon C; Abdel Wahab C; Azaïs H; Bendifallah S; Bolze PA; Brun JL; Canlorbe G; Chauvet P; Chereau E; Courbiere B; De La Motte Rouge T; Devouassoux-Shisheboran M; Eymerit-Morin C; Fauvet R; Gauroy E; Gauthier T; Grynberg M; Koskas M; Larouzee E; Lecointre L; Levêque J; Margueritte F; D'argent Mathieu E; Nyangoh-Timoh K; Ouldamer L; Raad J; Raimond E; Ramanah R; Rolland L; Rousset P; Rousset-Jablonski C; Thomassin-Naggara I; Uzan C; Zilliox M; Daraï E
    J Gynecol Obstet Hum Reprod; 2021 Jan; 50(1):101966. PubMed ID: 33144266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful elective and medically indicated oocyte vitrification and warming for autologous in vitro fertilization, with predicted birth probabilities for fertility preservation according to number of cryopreserved oocytes and age at retrieval.
    Doyle JO; Richter KS; Lim J; Stillman RJ; Graham JR; Tucker MJ
    Fertil Steril; 2016 Feb; 105(2):459-66.e2. PubMed ID: 26604065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What women want: Fertility sparing surgery in Borderline ovarian tumours patients and pregnancy outcome.
    Candotti G; Peiretti M; Mangili G; Bergamini A; Candiani M; Cioffi R; Mais V; Rabaiotti E; Bocciolone L
    Eur J Surg Oncol; 2020 May; 46(5):888-892. PubMed ID: 31722834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oocyte accumulation for fertility preservation in women with benign ovarian tumours with a history of previous surgery, multiple or large cysts.
    Legrand C; Keller L; Collinet P; Barbotin AL; Béhal H; Rubod C; Decanter C
    Reprod Biomed Online; 2021 Aug; 43(2):205-214. PubMed ID: 34247989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting the likelihood of live birth for elective oocyte cryopreservation: a counseling tool for physicians and patients.
    Goldman RH; Racowsky C; Farland LV; Munné S; Ribustello L; Fox JH
    Hum Reprod; 2017 Apr; 32(4):853-859. PubMed ID: 28166330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Live birth rate after use of cryopreserved oocytes or embryos at the time of cancer diagnosis in female survivors: a retrospective study of ten years of experience.
    Mayeur A; Puy V; Windal V; Hesters L; Gallot V; Benoit A; Grynberg M; Sonigo C; Frydman N
    J Assist Reprod Genet; 2021 Jul; 38(7):1767-1775. PubMed ID: 33797007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elective and Onco-fertility preservation: factors related to IVF outcomes.
    Cobo A; García-Velasco J; Domingo J; Pellicer A; Remohí J
    Hum Reprod; 2018 Dec; 33(12):2222-2231. PubMed ID: 30383235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second fertility-sparing surgery and fertility-outcomes in patients with recurrent borderline ovarian tumors.
    Wang L; Zhong Q; Tang Q; Wang H
    Arch Gynecol Obstet; 2022 Oct; 306(4):1177-1183. PubMed ID: 35396974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should we perform oocyte accumulation to preserve fertility in women with Turner syndrome? A multicenter study and systematic review of the literature.
    Brouillet S; Ranisavljevic N; Sonigo C; Haquet E; Bringer-Deutsch S; Loup-Cabaniols V; Hamamah S; Willems M; Anahory T
    Hum Reprod; 2023 Sep; 38(9):1733-1745. PubMed ID: 37381072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oocyte cryopreservation in two women with borderline ovarian tumor recurrence.
    Filippi F; Martinelli F; Somigliana E; Franchi D; Raspagliesi F; Chiappa V
    J Assist Reprod Genet; 2020 May; 37(5):1213-1216. PubMed ID: 32130615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Live birth using vitrified--warmed oocytes in invasive ovarian cancer: case report and literature review.
    Alvarez M; Solé M; Devesa M; Fábregas R; Boada M; Tur R; Coroleu B; Veiga A; Barri PN
    Reprod Biomed Online; 2014 Jun; 28(6):663-8. PubMed ID: 24745835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.